| Entry |
|
|---|
| Name |
Cenderitide (USAN) |
|---|
| Formula |
C158H263N49O50S3
|
|---|
| Exact mass |
3742.8706
|
|---|
| Mol weight |
3745.28
|
|---|
| Structure |
 |
|---|
| Sequence |
GLSKGCFGLK LDRIGSMSGL GCPSLRDPRP NAPSTSA
(dislfide brige: 6-22) |
|---|
| Type |
Peptide |
|---|
| Efficacy |
Antihypertensive, Diuretic, Atrial natriuretic peptide receptor agonist |
|---|
| Type |
Modified peptide |
|---|
| Comment |
designer natriuretic peptide
Treatment of acute, decompensated heart failure
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
Other
NPR1
D10063 Cenderitide (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
